TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment August 26, 1988